Related references
Note: Only part of the references are listed.Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation
Elizabeth Hall et al.
GYNECOLOGIC ONCOLOGY (2019)
Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
Michael G. Schrauder et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2019)
Complications in Postmastectomy Breast Reconstruction: One-year Outcomes of the Mastectomy Reconstruction Outcomes Consortium (MROC) Study
Edwin G. Wilkins et al.
ANNALS OF SURGERY (2018)
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
Joanne Kotsopoulos et al.
GYNECOLOGIC ONCOLOGY (2018)
Health Care Spending in the United States and Other High-Income Countries
Irene Papanicolas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers
Marta D'Alonzo et al.
CLINICAL BREAST CANCER (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
Dirk Mueller et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)
Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study
Maria-Dolores Chirlaque et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2017)
Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers
Laura J. Havrilesky et al.
GYNECOLOGIC ONCOLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
Adam N. Rosenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study
Andrea L. Pusic et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Emma Nolan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer
Reshma Jagsi et al.
JAMA SURGERY (2017)
RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Emma Nolan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol
Maria C. Katapodi et al.
JMIR RESEARCH PROTOCOLS (2017)
Impact of Bilateral Prophylactic Mastectomy and Immediate Reconstruction on Health-Related Quality of Life in Women at High Risk for Breast Carcinoma: Results of the Mastectomy Reconstruction Outcomes Consortium Study
Colleen M. McCarthy et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials
Steven J. Skates et al.
CLINICAL CANCER RESEARCH (2017)
Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer
Michael G. Schrauder et al.
BREAST (2017)
The experience of women carriers of BRCA mutations following risk- reducing surgery: A cultural perspective
Michal Mahat-Shamir et al.
HEALTH CARE FOR WOMEN INTERNATIONAL (2017)
AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users
P. Vemer et al.
PHARMACOECONOMICS (2016)
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
Andre Hennigs et al.
BMC CANCER (2016)
The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients
T. Huzarski et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO
M. Klar et al.
EUROPEAN JOURNAL OF CANCER (2016)
Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy
Paige E. Tucker et al.
GYNECOLOGIC ONCOLOGY (2016)
A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing
Klazien Matter-Walstra et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
Jonathan A. Ledermann et al.
LANCET ONCOLOGY (2016)
Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study
Walter A. Rocca et al.
MAYO CLINIC PROCEEDINGS (2016)
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
Zora Baretta et al.
MEDICINE (2016)
The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
Lynn C. Hartmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Is Single-Stage Prosthetic Reconstruction Cost Effective? A Cost-Utility Analysis for the Use of Direct-to-Implant Breast Reconstruction Relative to Expander-Implant Reconstruction in Postmastectomy Patients
Naveen M. Krishnan et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2016)
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
Xinglei Chai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
Xinglei Chai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Kelly Metcalfe et al.
JAMA ONCOLOGY (2015)
Nipple-Sparing Mastectomy in BRCA1/2 Mutation Carriers: An Interim Analysis and Review of the Literature
Katharine Yao et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation
K. A. Metcalfe et al.
CLINICAL GENETICS (2014)
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
Jack Cuzick et al.
LANCET (2014)
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Amanda B. Spurdle et al.
BREAST CANCER RESEARCH (2014)
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Karoline B. Kuchenbaecker et al.
BREAST CANCER RESEARCH (2014)
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer
Susan M. Domchek et al.
CANCER (2013)
Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage
Tianhui Chen et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study
Lisa M. Landrum et al.
GYNECOLOGIC ONCOLOGY (2013)
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kelly-Anne Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Jack Cuzick et al.
LANCET (2013)
Economic burden of cancer across the European Union: a population-based cost analysis
Ramon Luengo-Fernandez et al.
LANCET ONCOLOGY (2013)
The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation
Amy Finch et al.
PSYCHO-ONCOLOGY (2013)
Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study
Mariska den Heijer et al.
EUROPEAN JOURNAL OF CANCER (2012)
Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis
Daniel Bainbridge et al.
LANCET (2012)
Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies
Roberta Ara et al.
VALUE IN HEALTH (2012)
Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey
Brita Arver et al.
ANNALS OF SURGERY (2011)
Oophorectomy vs Ovarian Conservation With Hysterectomy
Vanessa L. Jacoby et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers
Victor R. Grann et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
Saundra S. Buys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Cost-Effectiveness of Contralateral Prophylactic Mastectomy Versus Routine Surveillance in Patients With Unilateral Breast Cancer
Benjamin Zendejas et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer
Judy C. Boughey et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Bilateral prophylactic mastectomy in women with inherited risk of breast cancer - Prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery
Jessica Gahm et al.
BREAST (2010)
Breast cancer-related preferences among women with and without BRCA mutations
Victor R. Grann et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS: UTILITY OR FUTILITY?
Rob Anderson
HEALTH ECONOMICS (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers
M. J. A. Kenkhuis et al.
MATURITAS (2010)
Health-state utility values in breast cancer
Tessa Peasgood et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment
Laura J. Havrilesky et al.
GYNECOLOGIC ONCOLOGY (2009)
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Monika K. Graeser et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2009)
Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers:: A cost-effectiveness analysis
Jan Norum et al.
EUROPEAN JOURNAL OF CANCER (2008)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Kelly A. Metcalfe et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: Long-term experiences at the rotterdam family cancer clinic
Bernadette A. M. Heemskerk-Gerritsen et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial
Jack Cuzick et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Twenty-year follow-up of the royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial
Trevor J. Powles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Preference-based EQ-5D index scores for chronic conditions in the United States
Patrick W. Sullivan et al.
MEDICAL DECISION MAKING (2006)
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
K Anderson et al.
ANNALS OF INTERNAL MEDICINE (2006)
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer
JB Madalinska et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Overview of the main outcomes in breast-cancer prevention trials
J Cuzick et al.
LANCET (2003)
Cost-utility analysis comparing free and pedicled tram flap for breast reconstruction
A Thoma et al.
MICROSURGERY (2003)
Survival in prospectively ascertained familial breast cancer:: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy
P Moller et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews
MB Hatcher et al.
BRITISH MEDICAL JOURNAL (2001)
Share Paper
